Is low-dose methotrexate nephrotoxic? Case report and review of the literature

Clinical Nephrology

Volumn 64, Issue 4, 2005, Pages 315-319

  Izzedine, Hassan ^a   Launay Vacher, V ^a   Karie, S ^a   Caramella, C ^a   de Person, F ^a   Deray, G ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Low dose MTX; Renal failure; Rheumatoid arthritis

Indexed keywords

ANALGESIC AGENT; CYTOTOXIC AGENT; FOLIC ACID; GOLD; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTHRITIS; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; FEMALE; GLOMERULOPATHY; HUMAN; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; LONG TERM CARE; NEPHROSCLEROSIS; NEPHROTOXICITY; RENOVASCULAR DISEASE;

EID: 26844441190     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp64315     Document Type: Article

References (31)

1. Abelson HT, Fosburg MT, Beardsley GP, Goorin AM, Gorka C, Link M, Link D 1983 Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J Clin Oncol 1: 208-216
2. Adu D, Tse WY 2001 Rheumatoid arthritis, mixed connective tissue disease, and polymyositis. Part IV, Chapter 18. In: Adu D, Emery P, Madaio MP (eds) Rheumatology and the Kidney. Oxforg University Press, pp 293-302
3. Adu D, Berisa F, Howie AJ, Emery P, Bacon PA, McConkey B, McGonigle RJ, Michaels J, Popert AJ 1993 Glomerulonephritis in rheumatoid arthritis. Br J Rheumatol 32: 1008-1011
4. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324
5. Baker H 1977 Methotrexate. The conservative treatment for psoriasis. In: Faber EM, Cox AJ (eds) Psoriasis. Proc 2nd Int Symp, York Medical Books, New York, pp 235-242
6. Bannwarth B, Pehourcq F, Schaeverbeke T, Dehais J 1996 Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis. Clin Pharmacokinet 30: 194-210
7. Chen TS, Wenczak BA, Huang KC 1983 Transport of methotrexate in cortical slices of monkey kidney: effect of organic anions and vincristine. J Pharmacol Exp Ther 226: 645-649
8. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F 2002 Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359: 1173-1177
9. Dupuis LL, Koren G, Shore A, Silverman ED, Laxer RM 1990 Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis. J Rheumatol 17: 1469-1473
10. Fries JF, Spitz PW, Williams CA, Bloch DA, Singh G, Hubert HB 1990 A toxicity index for comparison of side effects among different drugs. Arthritis Rheum 33: 121-130
11. Furst DE, Herman RA, Koehnke R, Ericksen N, Hash L, Riggs CE, Porras A, Veng-Pedersen P 1990 Effect of aspirin and sulindac on methotrexate clearance. J Pharm Sci 79: 782-786
12. Gabriel SB 2001 The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 27: 269-281
13. Garella S, Matarese RA 1984 Renal effects of prostaglandins and clinical adverse effects of non-steroidal anti-inflammatory agents. Medicine (Baltimore) 63: 165-181
14. Herman RA, Veng-Pedersen P, Hoffman J, Koehnke R, Furst DE 1989 Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients. J Pharm Sci 78: 165-171
15. Kraus A, Alarcon-Segovia D 1991 Low dose MTX and NSAID induced "mild" renal insufficiency and severe neutropenia. J Rheumatol 18: 1274
16. Kremer JM, Petrillo GF, Hamilton RA 1995 Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy. J Rheumatol 22: 38-40
17. Liegler DG 1969 The effect of organic acids on renal clearance of methotrexate in man. Clin Pharmacol Tber 10: 849-857
18. Mielants H, Veys EM, Van der Straeten C, Ackerman C, Goemaere S 1991 The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis: an open prospective study. J Rheumatol 18: 978-983
19. Murakami Y, Yamazaki K, Sakauchi N, Ogasawara H, Yamashita N, Masuda T, Tauchi K 1998 A one-month repeated oral dose toxicity study of methotrexate in unilaterally nephrectomized rats. J Toxicol Sci 23 (Suppl 5): S681-S699
20. Nierenberg DW 1983 Competitive inhibition of methotrexate accumulation in rabbit kidney slices by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 226: 1-6
21. Roenigh HH Jr, Fowler-Bergfeld W, Curtis GH 1969 Methotrexate for psoriasis in weekly oral doses. Arch Derm 99: 86-93
22. Salomon MI, Gallo G, Poon TP, Goldblat MV, Tchertkoff V 1974 The kidney in rheumatoid arthritis. A study based on renal biopsies. Nephron 12: 297-310
23. Seideman P, Muller-Suur R 1993 Renal effects of aspirin and low dose methotrexate in rheumatoid arthritis. Ann Rheum Dis 52: 613-615
24. Seideman P, Muller-Suur R, Ekman E 1993 Renal effects of low-dose methotrexate in rheumatoid arthritis. J Rheumatol 20: 1126-1128
25. Sellars L, Siamopoulos K, Wilkinson R, Leohapand T, Morley AR 1983 Renal biopsy appearances in rheumatoid disease. Clin Nephrol 20: 114-120
26. Sokka T, Pincus T 2002 Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients. J Rheumatol 29: 2521-2524
27. Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ 1994 The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 33: 735-739
28. Weinblatt ME 1985 Toxicity of low-dose methotrexate in rheumatoid arthritis. J Rheumatol 12 (Suppl 12): S35-S39
29. Willkens RF 1990 Resolve: methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis. Semin Arthritis Rheum 20: 76-80
30. Yazici Y, Sokka T, Kautiainen H, Swearingen C, Kulman I, Pincus T 2004 Long-term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely due to laboratory abnormalities. Ann Rheum Dis 64: 207-211
31. Zachariae H, Grunnet E, Sogaard H 1976 Accidental kidney biopsies in psoriasis. Br J Derm 94: 655-657